- Corporate
Mr. Steven D. Skolsky, Vice-Chairman
 |
Steven D. Skolsky, Vice-Chairman, was born in 1956, is a U.S. citizen, and holds a Bachelor of Arts degree in Biology from the University of North Carolina at Chapel Hill. Mr. Skolsky has over 28 years of general management and international pharmaceutical experience with emphasis on product strategy, commercialization and product development. He currently serves as the President and Chief Executive Officer of Sequoia Pharmaceuticals, a privately held, U.S. based company specializing in novel antiviral therapeutics. Prior to his appointment at Sequoia, he held the position of Chief Executive Officer at Trimeris, Inc, a publicly held company that discovered and commercialized Fuzeon®, a novel, first-in-class HIV therapeutic in collaboration with partner F. Hoffmann-La Roche. Previously, Mr. Skolsky served over 23 years at GlaxoSmithKline in a range of senior leadership roles, including Senior Vice President, Global Product Strategy and Clinical Development, and Managing Director of GSK’s operations in Australia and New Zealand. |
© 2010 Basilea Pharmaceutica Ltd.
